Yesterday, the President & CEO of BioLife Solutions (BLFS – Research Report), Michael Rice, sold shares of BLFS for $77.25K.
Category: Healthcare
Cowen & Co. Sticks to Its Hold Rating for Regeneron (REGN)
In a report released yesterday, Yaron Werber from Cowen & Co. maintained a Hold rating on Regeneron (REGN – Research
The VP & CFO of Neogen is Exercising Options
Today it was reported that the VP & CFO of Neogen (NEOG – Research Report), Steven Quinlan, exercised options to
Checkpoint Therapeutics (CKPT) Gets a Buy Rating from H.C. Wainwright
In a report released today, Joseph Pantginis from H.C. Wainwright reiterated a Buy rating on Checkpoint Therapeutics (CKPT – Research
Aravive (ARAV) Gets a Buy Rating from H.C. Wainwright
In a report released today, Joseph Pantginis from H.C. Wainwright maintained a Buy rating on Aravive (ARAV – Research Report),
Iovance Biotherapeutics (IOVA) Receives a Buy from H.C. Wainwright
In a report released today, Joseph Pantginis from H.C. Wainwright reiterated a Buy rating on Iovance Biotherapeutics (IOVA – Research
Intercept Pharma (ICPT) Receives a Buy from Oppenheimer
In a report released today, Jay Olson from Oppenheimer maintained a Buy rating on Intercept Pharma (ICPT – Research Report),